Oregano and Prostate Cancer Cells

Share this post with friends & family

Share on facebook
Share on google
Share on twitter
Share on linkedin

By Bhushankumar Patel, Vichiksha R. Shah and Supriya A. Bavadekar
Pharmaceutical Sciences, Long Island University, Brooklyn, NY

Carvacrol, a monoterpene phenol, is known to be present in the volatile oils of Thymus vulgaris, Carum copticum and Origanum vulgare, and has been shown to have anti-proliferative effects on various human cancer cell lines, such as breast cancer, hepatoma, leukemia, non-small cell lung cancer, and cervical cancer. However, its effect on prostate cancer cells has not yet been determined. The objective of this research was to investigate the anti-proliferative effects of carvacrol on an androgen-sensitive, metastatic human prostate cancer cell line, LNCaP. In this study, cells were treated with increasing concentrations of carvacrol, ranging from 10–7M to 3×10–3M, and viability was determined after 48 and 96 hr using the XTT cell proliferation assay. Carvacrol inhibited cell viability in a dose-dependent manner, and the resultant IC50 values were found to be 135 ?M and 11 ?M, respectively. Data from phosphatidylserine externalization assays suggest that carvacrol causes induction of apoptosis* in these cells. This is the first study that has identified the anti-proliferative effects of carvacrol in prostate cancer cells, and results suggest that the compound may be valuable as a potential therapeutic agent for prostate cancer. This study is supported by the Division of Pharmaceutical Sciences at Long Island University, Brooklyn, NY.

The FASEB Journal. 2012;26:1037.5

*In case you are not familiar with the word “apoptosis” it means that it stimulates cell death.

Share this post with friends & family

Share on facebook
Share on google
Share on twitter
Share on linkedin

Are you ready to start healing from the inside out?